Coya Therapeutics (COYA) Cash & Current Investments (2022 - 2025)
Historic Cash & Current Investments for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to $28.1 million.
- Coya Therapeutics' Cash & Current Investments fell 955.03% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year decrease of 955.03%. This contributed to the annual value of $38.3 million for FY2024, which is 1751.01% up from last year.
- Latest data reveals that Coya Therapeutics reported Cash & Current Investments of $28.1 million as of Q3 2025, which was down 955.03% from $29.8 million recorded in Q2 2025.
- Coya Therapeutics' 5-year Cash & Current Investments high stood at $38.3 million for Q4 2024, and its period low was $5.9 million during Q4 2022.
- Moreover, its 4-year median value for Cash & Current Investments was $30.4 million (2024), whereas its average is $26.2 million.
- In the last 5 years, Coya Therapeutics' Cash & Current Investments soared by 44985.52% in 2023 and then crashed by 1857.92% in 2025.
- Coya Therapeutics' Cash & Current Investments (Quarter) stood at $5.9 million in 2022, then surged by 449.86% to $32.6 million in 2023, then increased by 17.51% to $38.3 million in 2024, then decreased by 26.63% to $28.1 million in 2025.
- Its Cash & Current Investments stands at $28.1 million for Q3 2025, versus $29.8 million for Q2 2025 and $35.5 million for Q1 2025.